U.S. Code · Título 42
National research and demonstration centers
42 U.S.C. § 285b–4
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Heart, blood vessel, lung, blood diseases, and blood resources; utilization of centers for prevention programs
The Director of the Institute may provide, in accordance with subsection (c), for the development of—
The centers developed under paragraph (1) shall, in addition to being utilized for research, training, and demonstrations, be utilized for the following prevention programs for cardiovascular, pulmonary, and blood diseases:
Sickle cell anemia
The Director of the Institute shall provide, in accordance with subsection (c), for the development of ten centers for basic and clinical research into the diagnosis, treatment, and control of sickle cell anemia.
Cooperative agreements and grants for establishing and supporting; uses for Federal payments; period of support, additional periods
Federal payments made under a cooperative agreement or grant under paragraph (1) may be used for—
(July 1, 1944, ch. 373, title IV, § 422, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 839; amended Pub. L. 100–607, title I, § 128, Nov. 4, 1988, 102 Stat. 3055; Pub. L. 103–43, title V, § 502, June 10, 1993, 107 Stat. 158; Pub. L. 107–206, title I, § 804(c), Aug. 2, 2002, 116 Stat. 874.)